A document from the Federal Audit Court (TCU) pointed to “robust evidence of fraud” in bids by Sulminas Suplementos e Nutrição, a company that supplied the Brazilian Army with input for the production of chloroquine. The drug, whose use was encouraged by President Jair Bolsonaro (PL), has no proven effectiveness against Covid-19.
Obtained by Folha de São Paulo, the TCU document points out possible fraud in 26 bids between 2018 and 2021 – 24 were under the Bolsonaro government. Sulminas, which won 15 of the contracts, supplied diphosphate salt to the Army Chemical Pharmaceutical Laboratory.
+ Angotti changes secretariat in Health and will replace “Captain Chloroquine”
+ Secretary who defended chloroquine and attacked vaccine is relocated in Health
The TCU suspects that there is overpricing in the production of chloroquine by the Armed Forces. The technical area of the court requested the opening of a process to investigate suspicions of fraud and listen to Sulminas – the decision is up to the rapporteur, Minister Benjamin Zymler.
Sulminas states that the amounts involved in the bids are compatible with those of the market and has shown itself to be available to the authorities to provide any necessary clarifications.
The post TCU points out evidence of fraud by a supplier of chloroquine to the Army, says newspaper appeared first on ISTOÉ DINHEIRO.
#TCU #points #evidence #fraud #supplier #chloroquine #Army